Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Silgan (SLGN)

Silgan Q3 net sales rise 15% to $2.01 billion; full-year adjusted EPS outlook cut

Mixed Impact 4 of 5 guidance Written later

Silgan reported third quarter 2025 net sales of $2.01 billion, up 15%, and diluted EPS of $1.06, up from $0.93, with adjusted EPS of $1.22, up 1%. The company cut its full-year 2025 adjusted EPS estimate to $3.66 to $3.76 from $3.85 to $4.05, citing lower customer volume forecasts in North American personal and home care and higher tax and interest expense, which weighs on shareholder earnings expectations despite the stronger quarter.

Key points

  • Q3 2025 net sales $2.01 billion, up $263.6 million (15%) from $1.75 billion, driven mainly by the Weener acquisition and higher raw material pass-through costs
  • Q3 2025 net income $113.3 million, or $1.06 per diluted share, versus $100.1 million, or $0.93, a year earlier; adjusted EPS $1.22 versus $1.21
  • 2025 adjusted EPS estimate lowered to $3.66 to $3.76 from $3.85 to $4.05; Q4 2025 adjusted EPS estimate of $0.62 to $0.72 versus $0.85 in Q4 2024
  • Company confirmed 2025 free cash flow estimate of $430 million and raised 2025 interest expense estimate to about $190 million from about $185 million

The filing

CompanySilgan (SLGN)
Form8-K, current report
Filed with the SECOct 29, 2025, 4:30 PM ET
Accession number0001628280-25-047153

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.